Dec 15, 2025 I recently heard about some notable developments in the pharmaceutical sector, especially around the GLP-1 industry, which is gaining momentum due to its role in weight loss treatments. The market is currently led by Novo Nordisk and Eli Lilly. While Eli Lilly’s stock has been relatively stable
